Testicular cancer natural history, complications and prognosis

Revision as of 13:12, 12 June 2014 by Rim Halaby (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Testicular cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Testicular cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Testicular cancer natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Testicular cancer natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Testicular cancer natural history, complications and prognosis

CDC on Testicular cancer natural history, complications and prognosis

Testicular cancer natural history, complications and prognosis in the news

Blogs on Testicular cancer natural history, complications and prognosis

Directions to Hospitals Treating Testicular cancer

Risk calculators and risk factors for Testicular cancer natural history, complications and prognosis

Overview

The prognosis of testicular cancer is favorable since this type of cancer can be cured. Between 2004 and 2010, the 5-year relative survival of patients with testicular cancer was 96.6%.[1]

Complications

Testicular cancer may spread to other parts of the body. The most common sites include the:

Complications of surgery can include:

  • Bleeding and infection after surgery
  • Infertility (if both testicles are removed)
    • Infertility can occur among patients with testicular cancer. If the patient is of childbearing age, he should be informed about the possibility of infertility and the solutions to this problem, such as sperm banking.

Men who had testicular cancer are at an elevated risk of cancer in the other testis.

Prognosis

5-Year Survival

  • Between 2004 and 2010, the 5-year relative survival of patients with testicular cancer was 96.6%.[1]
  • When stratified by age, the 5-year relative survival of patients with testicular cancer was 95.4% and 86.4% for patients <65 and ≥ 65 years of age respectively.[1]
  • The survival of patients with testicular cancer varies with the stage of the disease. Shown below is a table depicting the 5-year relative survival by the stage of testicular cancer:[1]
Stage 5-year relative survival (%), (2004-2010)
All stages 95.3%
Localized 99.2%
Regional 96%
Distant 73.1%
Unstaged 78.8%
  • Shown below is an image depicting the 5-year conditional relative survival (probability of surviving in the next 5-years given the cohort has already survived 0, 1, 3 years) between 1998 and 2010 of testicular cancer by stage at diagnosis according to SEER. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[1]

5-year conditional relative survival (probability of surviving in the next 5-years given the cohort has already survived 0, 1, 3 years) between 1998 and 2010 of testicular cancer by stage at diagnosis according to SEER.

Recurrence

Patients who are diagnosed with testicular cancer should be followed up to detect any recurrence of the cancer. Follow up visits should be scheduled with the physician at time intervals that vary according to the type and stage of testicular cancer. During follow up visits, patients should undergo laboratory tests to measure the level of tumor markers as well as imaging.

References

  1. 1.0 1.1 1.2 1.3 1.4 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.


Template:WikiDoc Sources